Combined concomitant boost radiotherapy and chemotherapy in stage III–IV head and neck carcinomas: A comparison of toxicity and treatment results with those observed after radiotherapy alone
Open Access
- 1 July 1997
- journal article
- research article
- Published by Elsevier
- Vol. 8 (7) , 681-684
- https://doi.org/10.1023/a:1008260720076
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- 321 Hyperfractionated (HF) and accelerated (AF) radiotherapy (RT) in head and neck cancers: Facts from trials, impact on standard practiceEuropean Journal Of Cancer, 1995
- Head and Neck CancerNew England Journal of Medicine, 1993
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and RadiotherapyNew England Journal of Medicine, 1992
- Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynxInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Adjuvant chemotherapy in head and neck cancerBritish Journal of Cancer, 1990
- Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Twice-a-day radiation therapy for cancer of the head and neckCancer, 1985
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983